Paradigm Biopharmaceuticals Ltd.ASX: PAR

Phase 3 OA Trial to Proceed after Formal Safety Review

Dec 28, 2022 at 6:27 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment